Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

被引:202
作者
Walker, Joan L. [1 ]
Powell, C. Bethan [2 ]
Chen, Lee-may [3 ]
Carter, Jeanne [4 ]
Jump, Victoria L. Bae [5 ]
Parker, Lynn P. [6 ]
Borowsky, Mark E. [7 ]
Gibb, Randall K. [8 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73104 USA
[2] Kaiser Permanente San Francisco, Northern Calif Gynecol Canc Program, San Francisco, CA USA
[3] Univ Calif San Francisco, Mt Zion Canc Ctr, Div Gynecol Oncol, San Francisco, CA 94143 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[5] Univ N Carolina, Div Gynecol Oncol, Chapel Hill, NC USA
[6] Norton Canc Inst, Louisville, KY USA
[7] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE USA
[8] Billings Clin, Ctr Canc, Billings, MT USA
关键词
BRCA; carriers; Cascade genetic testing; fallopian tube; genetic testing; mastectomy; ovarian cancer; oral contraceptives; prevention; salpingectomy; risk-reducing bilateral salpingo-oophorectomy (BSO); REDUCING SALPINGO-OOPHORECTOMY; BRCA MUTATION CARRIERS; QUALITY-OF-LIFE; FALLOPIAN-TUBE EPITHELIUM; PELVIC SEROUS CARCINOMA; ORAL-CONTRACEPTIVE USE; HIGH-RISK WOMEN; PROPHYLACTIC SALPINGECTOMY; BREAST-CANCER; LAPAROSCOPIC SALPINGECTOMY;
D O I
10.1002/cncr.29321
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mortality from ovarian cancer may be dramatically reduced with the implementation of attainable prevention strategies. The new understanding of the cells of origin and the molecular etiology of ovarian cancer warrants a strong recommendation to the public and health care providers. This document discusses potential prevention strategies, which include 1) oral contraceptive use, 2) tubal sterilization, 3) risk-reducing salpingo-oophorectomy in women at high hereditary risk of breast and ovarian cancer, 4) genetic counseling and testing for women with ovarian cancer and other high-risk families, and 5) salpingectomy after childbearing is complete (at the time of elective pelvic surgeries, at the time of hysterectomy, and as an alternative to tubal ligation). The Society of Gynecologic Oncology has determined that recent scientific breakthroughs warrant a new summary of the progress toward the prevention of ovarian cancer. This review is intended to emphasize the importance of the fallopian tubes as a potential source of high-grade serous cancer in women with and without known genetic mutations in addition to the use of oral contraceptive pills to reduce the risk of ovarian cancer. Cancer 2015;121:2108-2120. (c) 2015 American Cancer Society.
引用
收藏
页码:2108 / 2120
页数:13
相关论文
共 157 条
[1]   Combining a symptoms index with CA 125 to improve detection of ovarian cancer [J].
Andersen, M. Robyn ;
Goff, Barbara A. ;
Lowe, Kimberly A. ;
Scholler, Nathalie ;
Bergan, Lindsay ;
Dresher, Charles W. ;
Paley, Pamela ;
Urban, Nicole .
CANCER, 2008, 113 (03) :484-489
[2]   Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer [J].
Andersen, M. Robyn ;
Goff, Barbara A. ;
Lowe, Kimberly A. ;
Scholler, Nathalie ;
Bergan, Lindsay ;
Drescher, Charles W. ;
Paley, Pamela ;
Urban, Nicole .
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) :378-383
[3]  
[Anonymous], OV CANC
[4]  
[Anonymous], 2010, OBSTET GYNECOL
[5]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[6]   Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study [J].
Antoniou, Antonis C. ;
Rookus, Matti ;
Andrieu, Nadine ;
Brohet, Richard ;
Chang-Claude, Jenny ;
Peock, Susan ;
Cook, Margaret ;
Evans, D. Gareth ;
Eeles, Rosalind ;
Nogues, Catherine ;
Faivre, Laurence ;
Gesta, Paul ;
van Leeuwen, Flora E. ;
Ausems, Margreet G. E. M. ;
Sorio, Ana ;
Caldes, Trinidad ;
Simard, Jacques ;
Lubinski, Jan ;
Gerdes, Anne-Marie ;
Olah, Edith ;
Fuerhauser, Christine ;
Olsson, Hakan ;
Arver, Brita ;
Radice, Paolo ;
Easton, Douglas F. ;
Goldgarl, David E. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) :601-610
[7]   Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy [J].
Benshushan, A. ;
Rojansky, N. ;
Chaviv, M. ;
Arbel-Alon, S. ;
Benmeir, A. ;
Imbar, T. ;
Brzezinski, A. .
CLIMACTERIC, 2009, 12 (05) :404-409
[8]  
Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1
[9]  
Berek JS., 2006, Holland-frei Cancer Medicine, V7th, P1543
[10]  
Blank SV, 2011, OBSTET GYNECOL, V117, P404, DOI 10.1097/AOG.0b013e3182083189